Statistics for Apricitabine: A Novel Deoxycytidine Analogue Nucleoside Reverse Transcriptase Inhibitor for the Treatment of Nucleoside-Resistant HIV Infection

Total visits

views
Apricitabine: A Novel Deoxycytidine Analogue Nucleoside Reverse Transcriptase Inhibitor for the Treatment of Nucleoside-Resistant HIV Infection 1

Total visits per month

views
mayo 2024 0
junio 2024 1
julio 2024 0
agosto 2024 0
septiembre 2024 0
octubre 2024 0
noviembre 2024 0

File Visits

views
10.1177095632020701800201.pdf 5